Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Newgenivf Group Limited's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Newgenivf Group Limited (NIVF) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2025
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q4 2025
Revenue Growth Y/Y
-
Q4 2025
Net Margin
205.84 %
Q4 2025

Key Findings: Newgenivf Group Limited vs Its Competitors

  • TTM: Trailing 12-month revenue of 5M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+300.0% annualized vs trailing 12 months).
  • Scale: Newgenivf Group Limited ranks #47 of 51 companies by market capitalization in the Healthcare Facilities industry, holding 0.0% of industry market cap.
  • Peer revenue share: Newgenivf Group Limited accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

NIVF Sales vs. its Competitors, Q4 2025

Newgenivf Group Limited generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/NIVF/competitors
https://api.csimarket.com/api/v1/companies/NIVF/relationships
https://api.csimarket.com/api/v1/companies/NIVF/similar
Programmatic access for models, analytics, and integration workflows.

Newgenivf Group Limited's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Newgenivf Group Limited - No No No
Similar-Size Competitors (5) 0% 0% 0% 80%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2025

100%market share
  • Newgenivf Group Limited100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Newgenivf Group Limited and its 0 tracked competitors.

See Newgenivf Group Limited's full market share breakdown »

NIVF Stock Performance relative to its Competitors

NIVF Competitors (weighted) Percent change over the selected range

Newgenivf Group Limited's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
100%beat U.S.A. 500
Similar-Size
(1 of 1)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Newgenivf Group Limited -99.60 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (1) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Newgenivf Group Limited's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

NIVF Stock Performance relative to Similar-Size Competitors

NIVF Similar-Size Competitors (equal-weighted, 6) Percent change over the selected range

Newgenivf Group Limited's Comment on Competition and Industry Peers

NewGenIvf operates in a competitive fertility market alongside other companies with longer operating histories, larger client bases, greater brand recognition, and more extensive financial, technical, and marketing resources. Competitors may differentiate themselves by developing or integrating more efficient solutions and services, achieving superior clinical outcomes, accessing networks of fertility specialists, establishing comprehensive data reporting systems, conducting marketing activities, and investing in or acquiring business partners. NewGenIvf provides a broad range of services within this market.